vs
Side-by-side financial comparison of EDGEWELL PERSONAL CARE Co (EPC) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $422.8M, roughly 1.5× EDGEWELL PERSONAL CARE Co). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -15.5%, a 18.9% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -11.6%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-137.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -16.0%).
The Edgewell Personal Care Company is an American multinational consumer products company headquartered in Shelton, Connecticut. It was formed in 2015 following the corporate spin-off from Energizer Holdings, Inc..
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
EPC vs HIMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $422.8M | $617.8M |
| Net Profit | $-65.7M | $20.6M |
| Gross Margin | 38.1% | 71.9% |
| Operating Margin | -4.5% | 1.5% |
| Net Margin | -15.5% | 3.3% |
| Revenue YoY | -11.6% | 28.4% |
| Net Profit YoY | -3028.6% | -20.8% |
| EPS (diluted) | $-1.41 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $422.8M | $617.8M | ||
| Q3 25 | $600.5M | $599.0M | ||
| Q2 25 | $627.2M | $544.8M | ||
| Q1 25 | $580.7M | $586.0M | ||
| Q4 24 | $415.1M | $481.1M | ||
| Q3 24 | $517.6M | $401.6M | ||
| Q2 24 | $647.8M | $315.6M | ||
| Q1 24 | $599.4M | $278.2M |
| Q4 25 | $-65.7M | $20.6M | ||
| Q3 25 | $-30.6M | $15.8M | ||
| Q2 25 | $29.1M | $42.5M | ||
| Q1 25 | $29.0M | $49.5M | ||
| Q4 24 | $-2.1M | $26.0M | ||
| Q3 24 | $8.8M | $75.6M | ||
| Q2 24 | $49.0M | $13.3M | ||
| Q1 24 | $36.0M | $11.1M |
| Q4 25 | 38.1% | 71.9% | ||
| Q3 25 | 37.9% | 73.8% | ||
| Q2 25 | 42.8% | 76.4% | ||
| Q1 25 | 44.1% | 73.5% | ||
| Q4 24 | 41.6% | 76.8% | ||
| Q3 24 | 41.1% | 79.2% | ||
| Q2 24 | 44.3% | 81.3% | ||
| Q1 24 | 43.1% | 82.4% |
| Q4 25 | -4.5% | 1.5% | ||
| Q3 25 | -4.2% | 2.0% | ||
| Q2 25 | 8.6% | 4.9% | ||
| Q1 25 | 10.1% | 9.9% | ||
| Q4 24 | 2.2% | 3.9% | ||
| Q3 24 | 3.9% | 5.6% | ||
| Q2 24 | 12.8% | 3.5% | ||
| Q1 24 | 11.7% | 3.6% |
| Q4 25 | -15.5% | 3.3% | ||
| Q3 25 | -5.1% | 2.6% | ||
| Q2 25 | 4.6% | 7.8% | ||
| Q1 25 | 5.0% | 8.4% | ||
| Q4 24 | -0.5% | 5.4% | ||
| Q3 24 | 1.7% | 18.8% | ||
| Q2 24 | 7.6% | 4.2% | ||
| Q1 24 | 6.0% | 4.0% |
| Q4 25 | $-1.41 | $0.08 | ||
| Q3 25 | $-0.65 | $0.06 | ||
| Q2 25 | $0.62 | $0.17 | ||
| Q1 25 | $0.60 | $0.20 | ||
| Q4 24 | $-0.04 | $0.10 | ||
| Q3 24 | $0.18 | $0.32 | ||
| Q2 24 | $0.98 | $0.06 | ||
| Q1 24 | $0.72 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.6M |
| Total DebtLower is stronger | $1.5B | — |
| Stockholders' EquityBook value | $1.5B | $540.9M |
| Total Assets | $3.8B | $2.2B |
| Debt / EquityLower = less leverage | 1.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | — | $220.6M | ||
| Q3 24 | $209.1M | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $1.5B | $540.9M | ||
| Q3 25 | $1.6B | $581.0M | ||
| Q2 25 | $1.6B | $562.7M | ||
| Q1 25 | $1.5B | $549.3M | ||
| Q4 24 | $1.5B | $476.7M | ||
| Q3 24 | $1.6B | $440.1M | ||
| Q2 24 | $1.6B | $362.0M | ||
| Q1 24 | $1.6B | $344.5M |
| Q4 25 | $3.8B | $2.2B | ||
| Q3 25 | $3.8B | $2.2B | ||
| Q2 25 | $3.8B | $1.9B | ||
| Q1 25 | $3.8B | $891.7M | ||
| Q4 24 | $3.7B | $707.5M | ||
| Q3 24 | $3.7B | $602.3M | ||
| Q2 24 | $3.7B | $480.5M | ||
| Q1 24 | $3.8B | $448.1M |
| Q4 25 | 1.03× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 0.97× | — | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-125.9M | $61.3M |
| Free Cash FlowOCF − Capex | $-137.5M | $-2.5M |
| FCF MarginFCF / Revenue | -32.5% | -0.4% |
| Capex IntensityCapex / Revenue | 2.7% | 10.3% |
| Cash ConversionOCF / Net Profit | — | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $36.3M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-125.9M | $61.3M | ||
| Q3 25 | $74.1M | $148.7M | ||
| Q2 25 | $114.8M | $-19.1M | ||
| Q1 25 | $45.1M | $109.1M | ||
| Q4 24 | $-115.6M | $86.4M | ||
| Q3 24 | $-388.3M | $85.3M | ||
| Q2 24 | $101.2M | $53.6M | ||
| Q1 24 | $129.0M | $25.8M |
| Q4 25 | $-137.5M | $-2.5M | ||
| Q3 25 | $46.5M | $79.3M | ||
| Q2 25 | $99.3M | $-69.5M | ||
| Q1 25 | $28.0M | $50.1M | ||
| Q4 24 | $-132.4M | $59.5M | ||
| Q3 24 | $-414.2M | $79.4M | ||
| Q2 24 | $88.6M | $47.6M | ||
| Q1 24 | $117.5M | $11.8M |
| Q4 25 | -32.5% | -0.4% | ||
| Q3 25 | 7.7% | 13.2% | ||
| Q2 25 | 15.8% | -12.8% | ||
| Q1 25 | 4.8% | 8.5% | ||
| Q4 24 | -31.9% | 12.4% | ||
| Q3 24 | -80.0% | 19.8% | ||
| Q2 24 | 13.7% | 15.1% | ||
| Q1 24 | 19.6% | 4.3% |
| Q4 25 | 2.7% | 10.3% | ||
| Q3 25 | 4.6% | 11.6% | ||
| Q2 25 | 2.5% | 9.3% | ||
| Q1 25 | 2.9% | 10.1% | ||
| Q4 24 | 4.0% | 5.6% | ||
| Q3 24 | 5.0% | 1.5% | ||
| Q2 24 | 1.9% | 1.9% | ||
| Q1 24 | 1.9% | 5.0% |
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | 3.95× | -0.45× | ||
| Q1 25 | 1.56× | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | -44.13× | 1.13× | ||
| Q2 24 | 2.07× | 4.03× | ||
| Q1 24 | 3.58× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPC
| Other | $242.0M | 57% |
| Sunand Skin Care Segment | $131.5M | 31% |
| Shavinggelsandcreams | $32.3M | 8% |
| Wipes And Other Skin Care Products | $17.0M | 4% |
HIMS
Segment breakdown not available.
